Evidence map›Paper›PMID 27670813›Full record

ArticleBritish journal of clinical pharmacology2017

A multifaceted intervention to reduce drug-related complications in surgical patients.

Jacqueline M Bos, Patricia M L A van den Bemt, Wietske Kievit, Johan L W Pot, J Elsbeth Nagtegaal, André Wieringa, Monique M L van der Westerlaken, Gert Jan van der Wilt, Peter A G M de Smet, Cornelis Kramers

Open access · bronzeAbstract read
In one paragraph

Article in British journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jacqueline M BosDepartment of Clinical Pharmacy, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Patricia M L A van den BemtDepartment of Clinical Pharmacy, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Wietske KievitDepartment of Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands.
Johan L W PotDepartment of Clinical Pharmacy, Meander Medical Centre, Amersfoort, the Netherlands.
J Elsbeth NagtegaalDepartment of Clinical Pharmacy, Meander Medical Centre, Amersfoort, the Netherlands.
André WieringaDepartment of Clinical Pharmacy, Isala Hospital, Zwolle, the Netherlands.
Monique M L van der WesterlakenDepartment of Clinical Pharmacy, Meander Medical Centre, Amersfoort, the Netherlands.
Gert Jan van der WiltDepartment of Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands.
Peter A G M de SmetDepartment Scientific Institute for Quality of Healthcare, Radboud University Medical Centre, Nijmegen, the Netherlands.
Cornelis KramersDepartment of Clinical Pharmacy, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Radboud University Medical Center · NLMeander Medisch Centrum · NLCanisius-Wilhelmina Ziekenhuis · NLErasmus University Rotterdam · NLIsala · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe P-REVIEW study was a prospective, multicenter, open intervention study, designed to determine whether a multifaceted intervention of educating the prescriber combined with medication review and pharmaceutical visits to the ward by the hospital pharmacist could lead to a reduction in drug-related complications among surgical patients.

methodsA total of 6780 admissions of 5940 patients to surgical, urological and orthopaedic wards during the usual care period and 6484 admissions of 5711 patients during the intervention period were included. An educational programme covering pain management, antithrombotics, fluid and electrolyte management, prescription in case of renal insufficiency and antibiotics was developed. National and local hospital guidelines were included. Hospital pharmacists performed medication safety consultations, combining medication review of high-risk patients and a visit to the physician on the ward.

resultsA significantly lower proportion of admissions with one or more clinically relevant, potentially preventable, drug-related problems (including death, temporary or sustained disability, increased length of hospital stay or readmission within 30 days) occurred in the intervention period (1.1% (73/6484) compared to the usual care period [1.6% (106/6780)] (P = 0.029). The relative risk (RR) was 0.72 (95% CI 0.53-0.97). Several types of drug-related problems occurred less frequently. Costs incurred as result of time spent on study-related activities were not different before and after the intervention.

conclusionsThe P-REVIEW study shows that education and support of the prescribing physician with respect to high-risk patients in surgical departments leads to a significant, clinically relevant benefit for patients without generating additional costs.

Indexed as

Pharmacy Service, HospitalDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleMiddle AgedNetherlandsPatient Education as TopicPharmacistsProfessional RoleProgram EvaluationProspective Studiesmedical educationmedication errorspatient safetyprescribing

Identifiers

PMID27670813
PMCPMC5306487
OpenAlexW2524951562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.